TY - JOUR T1 - <em>Correction: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner</em> JF - BMJ Open Diabetes Research &amp; Care JO - BMJ Open Diab Res Care DO - 10.1136/bmjdrc-2017-000391corr1 VL - 5 IS - 1 SP - e000391corr1 A2 - , Y1 - 2017/09/01 UR - http://drc.bmj.com/content/5/1/e000391corr1.abstract N2 - Kitada M, Shin-ichi T, Konishi K et al. Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 … ER -